Growth Metrics

Cumberland Pharmaceuticals (CPIX) Gains from Investment Securities (2019 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Gains from Investment Securities for 8 consecutive years, with $345082.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 63.72% to $345082.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $438311.0 through Dec 2025, up 2822.07% year-over-year, with the annual reading at $438311.0 for FY2025, 2822.07% up from the prior year.
  • Gains from Investment Securities hit $345082.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $9651.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.1 million in Q4 2023 to a low of -$983574.0 in Q3 2022.
  • Historically, Gains from Investment Securities has averaged $42128.4 across 5 years, with a median of -$99659.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: crashed 172.24% in 2023 and later surged 119.52% in 2025.
  • Year by year, Gains from Investment Securities stood at $632319.0 in 2021, then skyrocketed by 68.95% to $1.1 million in 2022, then rose by 5.45% to $1.1 million in 2023, then decreased by 15.58% to $951072.0 in 2024, then crashed by 63.72% to $345082.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for CPIX at $345082.0 in Q4 2025, $9651.0 in Q3 2025, and $38602.0 in Q2 2025.